Vol. 24 No. 2(84) (2020)

Vol. 24 No. 2(84) (2020)

Neurologijos seminarai
Published 2020-06-02

Front Matter

R. Mameniškienė
Redaktoriaus žodis
81
PDF

Review Articles

D. Valančius | V. Kasiulevičius
COVID-19 – a new challenge for the medical community
82-88
PDF
A. Jasionis | R. Mameniškienė
Neurological examination is changing
89-93
PDF
A. Vilionskis | R. Masiliūnas | A. Ekkert | D. Jatužis
Peculiarities and recommendations of acute stroke treatment during the COVID-19 pandemic
94-99
PDF
R. Kizlaitienė | N. Giedraitienė | I. Sereikė | J. Liutkienė | L. Leščinskienė | G. Kaubrys
Recommendations for the treatment of multiple sclerosis with disease-modifying drugs during the COVID-19 pandemic
100-104
PDF
A. Jasionis | R. Mameniškienė
COVID-19 infection: neurological symptoms and encephalitis
105-111
PDF
M. Vaišvilas | A. Jasionis | R. Mameniškienė
Epilepsy and COVID-19: challenges for the neurologist, patient, and national health system during a pandemic
112-118
PDF
E. Sakalauskaitė-Juodeikienė
COVID-19 infection, quarantine, and sleep disorders: literature review
119-124
PDF
R. Kaladytė Lokominienė
Parkinson’s disease and other movement disorders in the context of the SARS-COV-2 pandemic
125-131
PDF
K. Ryliškienė
Migraine consultation and treatment in the era of COVID-19
132-135
PDF
E. Audronytė | V. Sutnikienė | G. Kaubrys
Dementia care recommendations during the COVID-19 pandemic
136-137
PDF
A. Klimašauskienė | R. Bunevičiūtė
Myasthenia gravis and Lambert-Eaton myasthenic syndrome: treatment options and guidance for management during COVID-19 pandemic
138-144
PDF
R. Bunevičiūtė | A. Klimašauskienė
Inflammatory demyelinating polyneuropathies and patient management during the COVID-19 pandemic. Literature review
145-151
PDF
J. Valaikienė
Urgent neurosonological examinations during COVID-19 pandemic
152-157
PDF
A. Vaitkevičius
Medicinal products used for the treatment and prophylaxis of COVID-19
158-167
PDF